Doxorubicin Terminated Phase 2 Trials for Sarcomas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00002993Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
NCT00033644Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
NCT00544778Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma
NCT01104298Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS